deinove (ALDEI:Euronext Paris)

Executive Profile*

Background*

Dr. Philippe Pouletty, MD is a Co-founder and General Partner at Truffle Capital and also serves as its Managing Director. Dr. Pouletty is a Co-founder and General Partner at Truffle Venture, FCPR and serves as its Managing Director. Dr. Pouletty serves as the President at Splicos SAS. He is a Limited Partner at US VC funds, Sequoia, Sofinnova, Partech and JP Morgan. He founded SangStat in 1988, Conjuchem in 1993 and DrugAbuse Sciences in 1995. Dr. Pouletty served as ... the Chairman of the Board from December 1999 to 2005 and Chief Executive Officer from December 1999 to 2005 at DrugAbuse Sciences, Inc. and also served as the President. He served as Chief Executive Officer of Biomedical Diagnostics SA. Dr. Pouletty co-founded Clonatec in 1988 and served as a Director of Research from 1984 to 1988. Mr. Finance was an Intern in the Hopitaux de Paris and practiced Hematology and Immunology at two of Paris' leading hospitals. He serves as the Chairman of the Board for Deinove SA and has been its Director since January 27, 2010. He served as the Chairman of Biomedical Diagnostics SA. Dr. Pouletty serves as Honorary Chairman and Member of Administrative Council at France Biotech. He served as the Chairman of France Biotech from 2001 to 2009 and also served as its Honorary President. He served as Vice Chairman of Europabio. Dr. Pouletty serves as a Director of MyoPowers Medical Technologies SA, PlasmaPrime, BMD, Immune Targeting Systems Ltd., Theraclion SAS, Wittycell, Pharnext SAS, Symetis SA, Cytomics Systems SA and Neovacs SA. He has been a Director of CARMAT SAS since May 7, 2010. He has been Director of Vexim SAS since June 26, 2006. He serves as a Director of of Biomedical Diagnostics SA. He has been Member of Supervisory Board at Innate Pharma SA since December 2001 and previously served as its Director. Dr. Pouletty served as a Director of Drugabuse Sciences Inc. He served as Director of ConjuChem Inc. from 1997 to May 2008. Dr. Pouletty is a Member of the American Society of Addiction Medicine. He served as a Member of the ‘Conseil Stratégique pour l’Attractivité de la France. Dr. Pouletty is the Inventor of 29 patents and a co-author of 41 published scientific papers. Dr. Pouletty received an M.D. degree from University of Paris VI, an M.S. degrees in Immunology and Virology, laureate from Pasteur Institute, post-doctoral research fellow at Stanford University, and 1999 laureate of the American Liver Foundation.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
ALDEI:FP	€10.28 EUR	0.00

COMPETITOR COMPENSATION